Australia markets closed

Cisen Pharmaceutical Co., Ltd. (603367.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
17.86-0.84 (-4.49%)
At close: 3:00PM CST
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
3,942,908
4,112,786
3,808,078
2,962,517
2,564,801
Cost of revenue
1,657,547
1,750,682
1,621,743
1,449,230
1,499,302
Gross profit
2,285,360
2,362,103
2,186,336
1,513,286
1,065,500
Operating expenses
Research development
270,330
310,560
325,981
142,000
108,692
Selling general and administrative
1,334,198
1,367,715
1,145,204
811,758
510,915
Total operating expenses
1,740,063
1,824,654
1,614,722
1,074,344
756,919
Operating income or loss
545,297
537,449
571,614
438,942
308,581
Interest expense
1,439
264.0208
0
-596.4309
6,584
Income before tax
555,425
582,111
567,978
422,565
289,200
Income tax expense
62,415
67,317
64,924
56,887
44,570
Income from continuing operations
493,010
514,793
503,054
365,678
244,631
Net income
492,931
514,580
503,545
367,222
246,882
Net income available to common shareholders
492,931
514,580
503,545
367,222
246,882
Basic EPS
-
1.14
1.11
0.97
0.70
Diluted EPS
-
1.14
1.11
0.97
0.70
Basic average shares
-
451,386
453,644
378,579
352,688
Diluted average shares
-
451,386
453,644
378,579
352,688
EBITDA
-
746,859
745,565
609,824
495,256